Detected ·
OMass Therapeutics
$310MSeries C
OMass Therapeutics closed an oversubscribed $310M (£230M) Series C, co-led by Bain Capital Life Sciences, Forbion and Novo Holdings.
- Website
- www.omass.com
- linkedin.com/company/12654474
- Amount
- $310 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-10-23 16:13:17 UTC
- Signal ID
- e534de88-a830-4b19-a045-252987c9a7c8
As the API returns it
{
"id": "e534de88-a830-4b19-a045-252987c9a7c8",
"created_at": "2026-10-23T16:13:17.646189Z",
"company_name": "OMass Therapeutics",
"company_website_url": "www.omass.com",
"company_linkedin_url": "https://www.linkedin.com/company/12654474",
"event_type": "funding",
"funding_amount": 310000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*OMass Therapeutics closed an oversubscribed $310M (£230M) Series C, co-led by Bain Capital Life Sciences, Forbion and Novo Holdings.*"
}